Lilly Tino, the transgender influencer and TikTok content creator, well-known for her transition, discussing trans issues, and often posting controversial content online, announced that she was ...

Key Points Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's GLP-1 drugs may have more potential, but Novo Nordisk is ...

The Clark County Fire Department responded to a storage room fire in a parking garage at a resort on the Las Vegas Strip on Friday.

Eli Lilly and Novo Nordisk dominate the weight-loss drug market. But pharma companies like Amgen, Viking, Zealand, Structure, AstraZeneca and Roche are racing to catch up.

Two former DMV high school basketball stars from the Interstate Athletic Conference are headed to the NBA Summer League after standout college careers.

If you're looking for a top healthcare stock to buy that has much more upside in GLP-1, then going with Eli Lilly or Novo Nordisk can make much more sense at this stage.

Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed ...